These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24166831)

  • 1. Identification of a molecular target of a novel fungal metabolite, pyrrolizilactone, by phenotypic profiling systems.
    Futamura Y; Kawatani M; Muroi M; Aono H; Nogawa T; Osada H
    Chembiochem; 2013 Dec; 14(18):2456-63. PubMed ID: 24166831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrrolizilactone, a new pyrrolizidinone metabolite produced by a fungus.
    Nogawa T; Kawatani M; Uramoto M; Okano A; Aono H; Futamura Y; Koshino H; Takahashi S; Osada H
    J Antibiot (Tokyo); 2013 Oct; 66(10):621-3. PubMed ID: 23715039
    [No Abstract]   [Full Text] [Related]  

  • 3. Cystargolides, 20S Proteasome Inhibitors Isolated from Kitasatospora cystarginea.
    Gill KA; Berrué F; Arens JC; Carr G; Kerr RG
    J Nat Prod; 2015 Apr; 78(4):822-6. PubMed ID: 25769015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Natural Proteasome Inhibitors as Novel Anticancer Therapeutics: Current Status and Perspectives.
    Wang H; Yang Q; Dou QP; Yang H
    Curr Protein Pept Sci; 2018 Feb; 19(4):358-367. PubMed ID: 28079010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marizomib, a potent second generation proteasome inhibitor from natural origin.
    Ma L; Diao A
    Anticancer Agents Med Chem; 2015; 15(3):298-306. PubMed ID: 25403165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omuralide and vibralactone: differences in the proteasome- β-lactone-γ-lactam binding scaffold alter target preferences.
    List A; Zeiler E; Gallastegui N; Rusch M; Hedberg C; Sieber SA; Groll M
    Angew Chem Int Ed Engl; 2014 Jan; 53(2):571-4. PubMed ID: 24285701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Search for Inhibitors of the Ubiquitin-Proteasome System from Natural Sources for Cancer Therapy.
    Tsukamoto S
    Chem Pharm Bull (Tokyo); 2016; 64(2):112-8. PubMed ID: 26833439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore modeling technique applied for the discovery of proteasome inhibitors.
    Pautasso C; Troia R; Genuardi M; Palumbo A
    Expert Opin Drug Discov; 2014 Aug; 9(8):931-43. PubMed ID: 24877566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clogging the Ubiquitin-Proteasome Machinery with Marine Natural Products: Last Decade Update.
    Della Sala G; Agriesti F; Mazzoccoli C; Tataranni T; Costantino V; Piccoli C
    Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30486251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells.
    Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS
    Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated profiling methods for identifying the targets of bioactive compounds: MorphoBase and ChemProteoBase.
    Muroi M; Futamura Y; Osada H
    Nat Prod Rep; 2016 May; 33(5):621-5. PubMed ID: 26996806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibitors with photocontrolled activity.
    Hansen MJ; Velema WA; de Bruin G; Overkleeft HS; Szymanski W; Feringa BL
    Chembiochem; 2014 Sep; 15(14):2053-7. PubMed ID: 25125335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoinformatic expedition of the chemical space of fungal products.
    González-Medina M; Prieto-Martínez FD; Naveja JJ; Méndez-Lucio O; El-Elimat T; Pearce CJ; Oberlies NH; Figueroa M; Medina-Franco JL
    Future Med Chem; 2016 Aug; 8(12):1399-412. PubMed ID: 27485744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural products with antitumor activity from endophytic fungi.
    Wang LW; Zhang YL; Lin FC; Hu YZ; Zhang CL
    Mini Rev Med Chem; 2011 Oct; 11(12):1056-74. PubMed ID: 21861806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative chemoproteomic profiling reveals multiple target interactions of spongiolactone derivatives in leukemia cells.
    Wright MH; Tao Y; Drechsel J; Krysiak J; Chamni S; Weigert-Munoz A; Harvey NL; Romo D; Sieber SA
    Chem Commun (Camb); 2017 Nov; 53(95):12818-12821. PubMed ID: 29143030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphobase, an encyclopedic cell morphology database, and its use for drug target identification.
    Futamura Y; Kawatani M; Kazami S; Tanaka K; Muroi M; Shimizu T; Tomita K; Watanabe N; Osada H
    Chem Biol; 2012 Dec; 19(12):1620-30. PubMed ID: 23261605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer compounds derived from fungal endophytes: their importance and future challenges.
    Kharwar RN; Mishra A; Gond SK; Stierle A; Stierle D
    Nat Prod Rep; 2011 Jul; 28(7):1208-28. PubMed ID: 21455524
    [No Abstract]   [Full Text] [Related]  

  • 18. Fungal metabolites with anticancer activity.
    Evidente A; Kornienko A; Cimmino A; Andolfi A; Lefranc F; Mathieu V; Kiss R
    Nat Prod Rep; 2014 May; 31(5):617-27. PubMed ID: 24651312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of two direct C(sp3)-H functionalizations for total synthesis of (+)-lactacystin.
    Yoshioka S; Nagatomo M; Inoue M
    Org Lett; 2015 Jan; 17(1):90-3. PubMed ID: 25526222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-based screening of extracts of natural sources to search for inhibitors of the ubiquitin-proteasome system and identification of proteasome inhibitors from the fungus Remotididymella sp.
    Nishimura S; Hitora Y; Kawahara T; Tanabe M; Ogata E; Kato H; Srikoon P; Watanabe T; Tsukamoto S
    Bioorg Med Chem Lett; 2022 Mar; 59():128566. PubMed ID: 35063633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.